What are the authentic stories pharma should be telling? What are the four pillars that serve as a foundation of authenticity for pharma? Our speakers from Pfizer and Merck answered these questions and shared their perspectives on the importance of authenticity.
Explore Our Perspectives
HawkPartners consultants earn their professional reputations by questioning, exploring, strategizing, and analyzing. Our people post, publish and speak on a wide variety of timely marketing and strategy-related topics. Browse our featured posts below or select by subject from the archived blog and published items. Want to discuss anything you read? We welcome the conversation.
Learn how to align personalization and data privacy efforts to optimize the customer experience.
Our team identifies how and why consumer behaviors are influenced by their need to regain rational and emotional control.
HawkPartners offers five examples to optimize public health communications materials
As we recover from the trauma caused by the pandemic, many consumers find themselves in a state of shock. The HawkPartners 2021 Brand Authenticity Index™ provides an opportunity for brands to connect in new ways with consumers that are more engaged, connected, and open than before the pandemic began.
The emergency-use authorizations of COVID-19 vaccines are priming consumers for vaccine brand differentiation and presenting a novel marketing situation that tasks marketers with challenging master brand decisions.
The Chauvin jury trial is taking place against the backdrop of a national discussion about a divisive cultural issue – namely, the issues of race and policing in the United States. These pre-existing views bring unique challenges in selecting and connecting with a jury.
How do brands weave authenticity into their identity, and why does it matter? Our panelists from The Ritz-Carlton, Pfizer, and Peloton discuss how brands communicate who they are and what they stand for during a recent ARF Insights Studio.
During a recent Advertising Research Foundation Pharma Council event, Robert Duboff moderated a discussion of how behavioral economics can provide greater insight into the COVID-19 patient journey.